Plasma and Platelet microRNAs in Clopidogrel Low Response Patients

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

Also called NCT02447809

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; single masking; primary purpose diagnostic
Phase
Phase 4
Enrolled
  • 400 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT02447809
Start date
(registry gives no type) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT02447809. Randomized; single masking; primary purpose diagnostic. Start 2015-01 (registry gives no type); primary completion 2016-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Plasma and Platelet microRNAs in Clopidogrel Low Response Patients
Acronym
PPRC
Intervention (Drug)
Clopidogrel
Intervention (Drug)
acetylsalicylic acid (ASA)
Lead sponsor
The First Affiliated Hospital with Nanjing Medical University (class: other)
Collaborator
National Natural Science Foundation of China (class: other government)

Record details

Record id
cardio:ct-nct02447809
Content hash
0d882b3f582d2842b1c043130e9ced63b5fb1f70c2686011b13b97529c45ae82